PD-L1 expression in the microenvironment and the response to checkpoint inhibitors in head and neck squamous cell carcinoma

In head and neck squamous cell carcinoma (HNSCC), data from studies using checkpoint-inhibiting antibodies that target programmed death 1 (PD-1) or its ligand the programmed death ligand 1 (PD-L1) demonstrated outstanding clinical activity. Translational investigations also suggested some correlatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Evrard, D., Hourseau, M., Couvelard, A., Paradis, V., Gauthier, H., Raymond, E., Halimi, C., Barry, B., Faivre, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714503/
https://www.ncbi.nlm.nih.gov/pubmed/33299655
http://dx.doi.org/10.1080/2162402X.2020.1844403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714503/
https://www.ncbi.nlm.nih.gov/pubmed/33299655
http://dx.doi.org/10.1080/2162402X.2020.1844403

Ejemplares similares